Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
NCB-0846
i
Other names:
NCB 0846, NCB-0846
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Carna Biosci, National Cancer Center
Drug class:
Wnt signalling pathway inhibitor, TNIK inhibitor
Related drugs:
‹
PRI724 (5)
WNT974 (2)
SM04690 (2)
BC2059 (2)
CGX1321 (1)
XAV-939 (1)
OMP-18R5 (1)
CWP291 (0)
Circ0003039 (0)
E7386 (0)
KY1022 (0)
OMP-54F28 (0)
OTSA101-DTPA-90Y (0)
PRI724 (5)
WNT974 (2)
SM04690 (2)
BC2059 (2)
CGX1321 (1)
XAV-939 (1)
OMP-18R5 (1)
CWP291 (0)
Circ0003039 (0)
E7386 (0)
KY1022 (0)
OMP-54F28 (0)
OTSA101-DTPA-90Y (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
TNIK overexpression
Lung Non-Small Cell Squamous Cancer
TNIK overexpression
Lung Non-Small Cell Squamous Cancer
NCB-0846
Sensitive: D – Preclinical
NCB-0846
Sensitive
:
D
NCB-0846
Sensitive: D – Preclinical
NCB-0846
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login